Pharmaceutical company Novartis broke ground on a new manufacturing plant in Denton. The company purchased an existing three-building, special-use facility totaling 46,000 square feet on 20 acres at 2101 Shady Oaks Drive. Community Impact reports the pharmaceutical organization will produce drugs for radioligand therapy, a form of targeted radiation used to treat advanced forms of cancer. The Denton plant is expected to become operational in 202…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.